Bath & Body Works, Inc. $BBWI Shares Bought by Trexquant Investment LP

Key Points

• Trexquant Investment LP increased its stake in Bath & Body Works by 94.0%, purchasing an additional 75,747 shares, bringing its total to 156,359 shares valued at $4.74 million.
• Institutional investors now hold 95.14% of Bath & Body Works’ stock, reflecting significant confidence from hedge funds in the company's future.
• Bath & Body Works reported a quarterly earnings per share (EPS) of $0.37, meeting expectations, amidst a slight 0.8% decline in year-over-year revenue.

Trexquant Investment LP grew its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 94.0% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 156,359 shares of the company's stock after purchasing an additional 75,747 shares during the quarter. Trexquant Investment LP owned approximately 0.07% of Bath & Body Works worth $4,741,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. SVB Wealth LLC purchased a new position in shares of Bath & Body Works during the 1st quarter worth $35,000. Golden State Wealth Management LLC lifted its stake in shares of Bath & Body Works by 94.7% during the 1st quarter. Golden State Wealth Management LLC now owns 1,320 shares of the company's stock worth $40,000 after purchasing an additional 642 shares during the period. UMB Bank n.a. lifted its stake in shares of Bath & Body Works by 65.9% during the 1st quarter. UMB Bank n.a. now owns 1,501 shares of the company's stock worth $46,000 after purchasing an additional 596 shares during the period. Ancora Advisors LLC purchased a new position in shares of Bath & Body Works during the 4th quarter worth $67,000. Finally, GKV Capital Management Co. Inc. purchased a new position in shares of Bath & Body Works during the 1st quarter worth $69,000. Hedge funds and other institutional investors own 95.14% of the company's stock.

Bath & Body Works Trading Down 7.4%

NYSE:BBWI traded down $2.37 during mid-day trading on Friday, hitting $29.50. The company had a trading volume of 6,612,009 shares, compared to its average volume of 5,241,885. The business has a fifty day simple moving average of $30.75 and a 200-day simple moving average of $30.65. Bath & Body Works, Inc. has a 1 year low of $24.94 and a 1 year high of $41.87. The firm has a market capitalization of $6.08 billion, a price-to-earnings ratio of 8.77, a PEG ratio of 1.05 and a beta of 1.49.

Bath & Body Works (NYSE:BBWI - Get Free Report) last released its quarterly earnings data on Thursday, August 28th. The company reported $0.37 EPS for the quarter, meeting the consensus estimate of $0.37. Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.The company had revenue of $1.55 billion for the quarter, compared to analyst estimates of $1.55 billion. During the same period last year, the company posted $0.37 earnings per share. The firm's revenue was down .8% compared to the same quarter last year. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. As a group, research analysts anticipate that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.

Bath & Body Works Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 5th. Shareholders of record on Friday, August 22nd will be given a $0.20 dividend. The ex-dividend date of this dividend is Friday, August 22nd. This represents a $0.80 annualized dividend and a yield of 2.7%. Bath & Body Works's dividend payout ratio (DPR) is 23.74%.

Analysts Set New Price Targets

BBWI has been the topic of a number of recent analyst reports. Piper Sandler set a $39.00 price target on Bath & Body Works and gave the stock an "overweight" rating in a research note on Thursday, May 15th. Wall Street Zen lowered Bath & Body Works from a "buy" rating to a "hold" rating in a research report on Saturday, August 9th. UBS Group dropped their price target on Bath & Body Works from $36.00 to $32.00 and set a "neutral" rating for the company in a research note on Friday, August 29th. Telsey Advisory Group restated an "outperform" rating and set a $38.00 price target on shares of Bath & Body Works in a research note on Thursday, August 28th. Finally, The Goldman Sachs Group dropped their price target on Bath & Body Works from $44.00 to $43.00 and set a "buy" rating for the company in a research note on Friday, May 30th. Twelve research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $41.62.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.